137 related articles for article (PubMed ID: 14634347)
1. [Effects of octreotide on small bowel obstructions in rats].
Cho JH; Kang HG; Kim SH; Lee HS; Lee KR; Kang HY
Korean J Gastroenterol; 2003 Oct; 42(4):283-8. PubMed ID: 14634347
[TBL] [Abstract][Full Text] [Related]
2. Improvement in survival of mice with proximal small bowel obstruction treated with octreotide.
Gittes GK; Nelson MT; Debas HT; Mulvihill SJ
Am J Surg; 1992 Feb; 163(2):231-3. PubMed ID: 1739178
[TBL] [Abstract][Full Text] [Related]
3. Effects of octreotide and a-tocopherol on bacterial translocation in experimental intestinal obstruction: a microbiological, light and electronmicroscopical study.
Reis E; Kama NA; Coskun T; Korkusuz P; Ors U; Aksoy M; Kulaçoglu S
Hepatogastroenterology; 1997; 44(15):656-63. PubMed ID: 9222666
[TBL] [Abstract][Full Text] [Related]
4. Improvement in the intestinal processes of hydroelectrolytic absorption and secretion in abdominal pathologies of surgical interest treated with SMS 201-995: experimental protocol.
Guiró FF; Bertolini G; Salas JV
Surg Today; 1999; 29(5):419-30. PubMed ID: 10333412
[TBL] [Abstract][Full Text] [Related]
5. Comparison of octreotide administration vs conservative treatment in the management of inoperable bowel obstruction in patients with far advanced cancer: a randomized, double- blind, controlled clinical trial.
Mystakidou K; Tsilika E; Kalaidopoulou O; Chondros K; Georgaki S; Papadimitriou L
Anticancer Res; 2002; 22(2B):1187-92. PubMed ID: 12168923
[TBL] [Abstract][Full Text] [Related]
6. Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction.
Mercadante S; Ripamonti C; Casuccio A; Zecca E; Groff L
Support Care Cancer; 2000 May; 8(3):188-91. PubMed ID: 10789958
[TBL] [Abstract][Full Text] [Related]
7. Octreotide for malignant bowel obstruction: twenty years after.
Mercadante S; Porzio G
Crit Rev Oncol Hematol; 2012 Sep; 83(3):388-92. PubMed ID: 22277783
[TBL] [Abstract][Full Text] [Related]
8. Octreotide may prevent definitive intestinal obstruction.
Mercadante S; Kargar J; Nicolosi G
J Pain Symptom Manage; 1997 Jun; 13(6):352-5. PubMed ID: 9204656
[TBL] [Abstract][Full Text] [Related]
9. Effects of octreotide acetate and Saccharomyces boulardii on bacterial translocation in an experimental intestinal loop obstruction model of rats.
Aldemir M; Kökoğlu OF; Geyik MF; Büyükbayram H
Tohoku J Exp Med; 2002 Sep; 198(1):1-9. PubMed ID: 12498309
[TBL] [Abstract][Full Text] [Related]
10. Multicenter prospective study on efficacy and safety of octreotide for inoperable malignant bowel obstruction.
Hisanaga T; Shinjo T; Morita T; Nakajima N; Ikenaga M; Tanimizu M; Kizawa Y; Maeno T; Shima Y; Hyodo I
Jpn J Clin Oncol; 2010 Aug; 40(8):739-45. PubMed ID: 20410056
[TBL] [Abstract][Full Text] [Related]
11. The role of octreotide in malignant bowel obstruction.
Krammer LM
Oncol Nurs Forum; 1999 Jun; 26(5):831-2. PubMed ID: 10382174
[No Abstract] [Full Text] [Related]
12. Octreotide in the treatment of small intestinal dysfunction after a model of jejunoileal autotransplantation in the pig.
Pakarinen MP; Lauronen J; Pirinen P; Kuusanmäki P; Raivio P; Halttunen J
Pediatr Surg Int; 2004 Oct; 20(10):791-6. PubMed ID: 15322839
[TBL] [Abstract][Full Text] [Related]
13. [A clinical study using octreotide in relieving gastrointestinal symptoms due to bowel obstruction in a terminally ill cancer patient].
Shima Y; Yamaguchi K; Miyata Y; Hyodo I; Yagi Y; Honke Y
Gan To Kagaku Ryoho; 2004 Sep; 31(9):1377-82. PubMed ID: 15446560
[TBL] [Abstract][Full Text] [Related]
14. Octreotide in the management of bowel obstruction in terminal ovarian cancer.
Mangili G; Franchi M; Mariani A; Zanaboni F; Rabaiotti E; Frigerio L; Bolis PF; Ferrari A
Gynecol Oncol; 1996 Jun; 61(3):345-8. PubMed ID: 8641613
[TBL] [Abstract][Full Text] [Related]
15. Octreotide in malignant intestinal obstruction.
Pandha HS; Waxman J
Anticancer Drugs; 1996 Jan; 7 Suppl 1():5-10. PubMed ID: 8822079
[TBL] [Abstract][Full Text] [Related]
16. How to use octreotide for malignant bowel obstruction.
Ripamonti C; Mercadante S
J Support Oncol; 2004; 2(4):357-64. PubMed ID: 15357519
[No Abstract] [Full Text] [Related]
17. Protective effects of baicalin and octreotide on intestinal mucosa of rats with severe acute pancreatitis.
Zhang X; Feng G; Weng W; Liang J; Lin N; Cai Y; Xu R; Zhou N; Yuan M; Yuan W; Xia X
Turk J Gastroenterol; 2009 Jun; 20(2):108-15. PubMed ID: 19530043
[TBL] [Abstract][Full Text] [Related]
18. Effects of octreotide on healing of intestinal anastomosis following small bowel obstruction in rats.
Yamaner S; Buğra D; Müslümanoğlu M; Bulut T; Cubukçu O; Ademoğlu E
Dis Colon Rectum; 1995 Mar; 38(3):308-12. PubMed ID: 7882799
[TBL] [Abstract][Full Text] [Related]
19. Role of octreotide, scopolamine butylbromide, and hydration in symptom control of patients with inoperable bowel obstruction and nasogastric tubes: a prospective randomized trial.
Ripamonti C; Mercadante S; Groff L; Zecca E; De Conno F; Casuccio A
J Pain Symptom Manage; 2000 Jan; 19(1):23-34. PubMed ID: 10687323
[TBL] [Abstract][Full Text] [Related]
20. Octreotide prevents the pathological alterations of bowel obstruction in cancer patients.
Mercadante S; Avola G; Maddaloni S; Salamone G; Aragona F; Rodolico V
Support Care Cancer; 1996 Sep; 4(5):393-4. PubMed ID: 8883235
[No Abstract] [Full Text] [Related]
[Next] [New Search]
